Researchers Fail to Find a Cure for MPS Through Genome Editing

The Daily News recently published an announcement by researchers at Sangamo Therapeutics showing the results of its first human trial to treat two rare genetic disorders through gene-editing technology. Gene-editing (or…

Continue Reading Researchers Fail to Find a Cure for MPS Through Genome Editing
North Carolina Has Added Three More Conditions to Their Newborn Screening Program
Source: Pixabay

North Carolina Has Added Three More Conditions to Their Newborn Screening Program

Lawmakers in the U.S. state of North Carolina have expanded the state’s newborn screening testing to include three more conditions. These are Pompe disease, Mucopolysaccharidosis type 1 (MPS 1), and…

Continue Reading North Carolina Has Added Three More Conditions to Their Newborn Screening Program
Is This What the MPS Research Community Been Missing?
Source: pixabay.com

Is This What the MPS Research Community Been Missing?

Recent findings from research done at the University of Pennslyvania indicate a new biomarker associated with a group of rare metabolic diseases called mucopolysaccharidoses (MPS). A biomarker is a measurable…

Continue Reading Is This What the MPS Research Community Been Missing?
Close Menu